Vela's SARS-CoV-2 test cleared for Europe

LabPulse.com staff writers
Apr 23, 2020
2019 05 02 23 38 2538 Check Mark 400

Vela Diagnostics has received the CE-IVD Mark in Europe for the manual version of its reverse transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2.

The ViroKey SARS-CoV-2 RT-PCR test targets conserved regions of the coronavirus genome. This version enables quick adoption of the test by laboratories with existing Applied Biosystems 7500 Fast Dx (ABI 7500 Fast Dx) instruments, according to Vela.

An automated version of the test, which the company said is slated to receive CE-IVD registration soon, can be used with a Sentosa SX101 instrument in conjunction with the Sentosa SA201 instrument or the ABI 7500 Fast Dx.

Latest in PCR
Money Bag Grant Award Social
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
March 4, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Coronavirus Covid Blue Social
Researchers develop technique for onsite detection of SARS-CoV-2
October 10, 2023
Test Tubes Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
October 9, 2023
Related Stories
2020 04 28 19 25 1337 Sequencing Dna Rna Pcr 400
Urinary Tract Infection
Vela launches new PCR test for detecting urinary tract infection
2020 04 28 19 25 1337 Sequencing Dna Rna Pcr 400
COVID-19
Vela promotes new pooling capability for SARS-CoV-2 test
2020 05 08 21 55 4265 2020 03 12 Sars Co V 2 400
COVID-19
Vela Diagnostics adds 2 SARS-CoV-2 assays
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in PCR
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Thermo Fisher launches new instrument, kit for respiratory testing
By LabPulse.com staff writers
Thermo Fisher Scientific has launched a nucleic acid purification instrument and kit for automated viral and bacterial respiratory testing.
December 11, 2023
Influenza Virus Social
Researchers develop technique for onsite detection of SARS-CoV-2
By LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Coronavirus Covid Blue Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
By LabPulse.com staff writers
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
Test Tubes Social
Nonprofit health system adopts Immunexpress test for detecting sepsis
By Nick Paul Taylor
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
ChromaCode starts early-access launch of lung cancer variant test
By Nick Paul Taylor
The test is designed to address diagnostic problems that prevent patients from undergoing timely cancer biomarker testing and receiving targeted therapies.
August 15, 2023
Lung Cancer Hotspot Social
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
By LabPulse.com staff writers
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
Bladder Urinary 3 D Social
Roche receives WHO prequalification for HPV screening tool
By LabPulse.com staff writers
Prequalification helps expand access to the screening tool in countries that rely on the WHO's list of prequalified suppliers in making purchasing and implementation decisions.
June 13, 2023
Lab Woman Dna Social
Eurobio Scientific obtains IVDR CE markings for PCR tests
By LabPulse.com staff writers
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
By LabPulse.com staff writers
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
BioMĂ©rieux receives FDA CLIA waiver for multiplex PCR respiratory panel
By LabPulse.com staff writers
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Patient Doctor Women Social
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
By LabPulse.com staff writers
Bio-Rad shares were down on Friday, a day after the firm updated its financial outlook for full-year 2023; it anticipates non-GAAP currency-neutral revenue growth of approximately 4.5% compared to its previous estimate of 6% to 7%.
May 5, 2023
Business Financial Results Social
Page 1 of 23
Next Page